159 related articles for article (PubMed ID: 37216130)
1. Paradoxical Left Ventricular Hypertrophy by Echocardiogram and Low Voltage ECG: A Key Clue in the Diagnostic Workup of Two Distinct Presentations of Cardiac AL Amyloidosis.
Tolu-Akinnawo O; Oyeleye K; Thayer T
Cureus; 2023 May; 15(5):e39143. PubMed ID: 37216130
[TBL] [Abstract][Full Text] [Related]
2. Cardiac amyloidosis: a review of the literature.
de Marneffe N; Dulgheru R; Ancion A; Moonen M; Lancellotti P
Acta Cardiol; 2022 Oct; 77(8):683-692. PubMed ID: 35852493
[TBL] [Abstract][Full Text] [Related]
3. Cardiac amyloidosis: updates in diagnosis and management.
Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
[TBL] [Abstract][Full Text] [Related]
4. Echocardiographic and electrocardiographic presentations of patients with endomyocardial biopsy-proven cardiac amyloidosis.
Roslan A; Kamsani SH; Nay TW; Tan KL; Hakim N; Tan AM; Megat Samsudim WN; Tan KL; Jauhari AT; Krishnan M; Leong D; Supramaniam T; Tan LK; Nuruddin AA
Med J Malaysia; 2018 Dec; 73(6):388-392. PubMed ID: 30647209
[TBL] [Abstract][Full Text] [Related]
5. Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis.
Bistola V; Parissis J; Foukarakis E; Valsamaki PN; Anastasakis A; Koutsis G; Efthimiadis G; Kastritis E
Heart Fail Rev; 2021 Jul; 26(4):861-879. PubMed ID: 33452596
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Electrocardiographic Follow-Up of a Patient with Light-Chain Cardiac Amyloidosis.
Ohara T; Murata H; Yodogawa K; Yasutake M
J Nippon Med Sch; 2022 Mar; 89(1):119-125. PubMed ID: 33692307
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Resonance in Transthyretin Cardiac Amyloidosis.
Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Zumbo G; Knight DS; Kotecha T; Francis R; Hutt DF; Rezk T; Rosmini S; Quarta CC; Whelan CJ; Kellman P; Gillmore JD; Moon JC; Hawkins PN; Fontana M
J Am Coll Cardiol; 2017 Jul; 70(4):466-477. PubMed ID: 28728692
[TBL] [Abstract][Full Text] [Related]
8. Cardiac Amyloidosis with Discordant QRS Voltage between Frontal and Precordial Leads.
Eötvös CA; Lazar RD; Zehan IG; Lévay-Hail EB; Pastiu G; Pop M; Bojan AS; Pop S; Blendea D
Medicina (Kaunas); 2021 Jun; 57(7):. PubMed ID: 34199044
[TBL] [Abstract][Full Text] [Related]
9. Senile Systemic Amyloidosis: An Underdiagnosed Disease.
Manso MC; Marques DP; Rocha SL; Rodeia SC; Domingos R
Eur J Case Rep Intern Med; 2017; 4(9):000725. PubMed ID: 30755970
[TBL] [Abstract][Full Text] [Related]
10. Case report regarding the evolution of electrocardiographic and echocardiographic features in cardiac amyloidosis.
Vervaat FE; Bouwmeester S; Vlaar PJ
Eur Heart J Case Rep; 2021 Jan; 5(1):ytaa426. PubMed ID: 33644637
[TBL] [Abstract][Full Text] [Related]
11. Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes.
Dubrey SW; Cha K; Skinner M; LaValley M; Falk RH
Heart; 1997 Jul; 78(1):74-82. PubMed ID: 9290406
[TBL] [Abstract][Full Text] [Related]
12. Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis.
Tanaka K; Essick EE; Doros G; Tanriverdi K; Connors LH; Seldin DC; Sam F
J Am Heart Assoc; 2013 Mar; 2(2):e005868. PubMed ID: 23537813
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of clinical and imaging features of cardiac amyloidosis: a multicenter study].
Zhang L; Tang H; Chen L; Wu X; Cheng L; Wang Z; Wang Y; Huang H; Li J; Wang J; Feng B; Zhi G
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):295-302. PubMed ID: 24670437
[TBL] [Abstract][Full Text] [Related]
14. Differential Myocyte Responses in Patients with Cardiac Transthyretin Amyloidosis and Light-Chain Amyloidosis: A Cardiac MR Imaging Study.
Fontana M; Banypersad SM; Treibel TA; Abdel-Gadir A; Maestrini V; Lane T; Gilbertson JA; Hutt DF; Lachmann HJ; Whelan CJ; Wechalekar AD; Herrey AS; Gillmore JD; Hawkins PN; Moon JC
Radiology; 2015 Nov; 277(2):388-97. PubMed ID: 25997029
[TBL] [Abstract][Full Text] [Related]
15. New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis.
Perlini S; Mussinelli R; Salinaro F
Curr Heart Fail Rep; 2016 Dec; 13(6):267-272. PubMed ID: 27900617
[TBL] [Abstract][Full Text] [Related]
16. Cardiac amyloidosis: in search of the ideal diagnostic tool.
Mavrogeni SI; Vartela V; Ntalianis A; Vretou R; Ikonomidis I; Tselegkidou M; Paraskevaidis I; Markousis-Mavrogenis G; Noutsias M; Rigopoulos A; Kolovou G; Kastritis E
Herz; 2021 Apr; 46(Suppl 1):9-14. PubMed ID: 31796976
[TBL] [Abstract][Full Text] [Related]
17. Cardiac amyloidosis masquerading as biventricular hypertrophy in a patient with multiple myeloma.
Basha HI; Raj E; Bachuwa G
BMJ Case Rep; 2013 Jul; 2013():. PubMed ID: 23897372
[TBL] [Abstract][Full Text] [Related]
18. Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value.
Cipriani A; De Michieli L; Porcari A; Licchelli L; Sinigiani G; Tini G; Zampieri M; Sessarego E; Argirò A; Fumagalli C; De Gaspari M; Licordari R; Russo D; Di Bella G; Perfetto F; Autore C; Musumeci B; Canepa M; Merlo M; Sinagra G; Gregori D; Iliceto S; Perazzolo Marra M; Cappelli F; Rapezzi C
JACC CardioOncol; 2022 Nov; 4(4):458-470. PubMed ID: 36444225
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.
Biolo A; Ramamurthy S; Connors LH; O'Hara CJ; Meier-Ewert HK; Soo Hoo PT; Sawyer DB; Seldin DC; Sam F
Circ Heart Fail; 2008 Nov; 1(4):249-57. PubMed ID: 19808299
[TBL] [Abstract][Full Text] [Related]
20.
Tahara N; Lairez O; Endo J; Okada A; Ueda M; Ishii T; Kitano Y; Lee HE; Russo E; Kubo T
ESC Heart Fail; 2022 Feb; 9(1):251-262. PubMed ID: 34841715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
